J&J Medical Connect
BALVERSA®

(erdafitinib)

+ Save link
J&J Medical Connect

Connect with us

Connect with us

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

BALVERSA® (erdafitinib)

Medical Information

BALVERSA – Specialty Pharmacy and Specialty Distributors

Last Updated: 01/23/2025

BACKGROUND

  • BALVERSA® (erdafitinib) is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC) with susceptible FGFR3 genetic alterations whose disease has progressed on or after at least one line of prior systemic therapy.1
    • Select patients for therapy based on an FDA-approved companion diagnostic for BALVERSA.
  • Limitations of Use: BALVERSA is not recommended for the treatment of patients who are eligible for and have not received prior PD-1 or PD-L1 inhibitor therapy.

Accessing BALVERSA through Specialty distributors

  • Access to BALVERSA is restricted to distribution via the following Specialty Distributors: ASD Healthcare and Oncology Supply.
  • Please contact ASD Healthcare or Oncology Supply directly for further inquiries related to accessing BALVERSA.

Specialty Distributor Contact Information2
Specialty Distributor
Phone
Fax
Email
Website
ASD Healthcare
800-746-6273
800-547-9413
[email protected]
www.ASDHealthcare.com
Oncology Supply
800-633-7555
800-248-8205
[email protected]
www.oncologysupply.com

Accessing BALVERSA through a Specialty Pharmacy

  • Johnson & Johnson offers BALVERSA access and patient services through CVS Specialty®. Please contact CVS Specialty directly for further inquiries related to accessing BALVERSA.

CVS Specialty Contact Information3
Specialty Pharmacy
Phone
Fax
Website
CVS Specialty
1-855-539-4712
1-888-435-1256
www.CVSSpecialty.com

References

Show
1 BALVERSA (erdafitinib) [Prescribing Information]. Horsham, PA: Janssen Products, LP;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/BALVERSA-pi.pdf
2 Access to BALVERSA: Specialty Distributor and Specialty Pharmacy Information Overview Brochure. Janssen Biotech, Inc. 2020. Updated 12/2024.  
3 CVS Specialty Oncology Oral Medications Solid Tumors Enrollment Form. Updated 1/17/2024. Accessed 1/6/2025. Available at: https://www.cvsspecialty.com/content/dam/enterprise/specialty/enrollment_forms/us/US_Oncology_Orals_Solid_Tumors.pdf